Zobrazeno 1 - 10
of 507
pro vyhledávání: '"J, Changalucha"'
Autor:
K.R. Mitchell, T. Erio, H.S. Whitworth, G. Marwerwe, J. Changalucha, K. Baisley, C.J. Lacey, R. Hayes, S. de SanJosé, D. Watson-Jones
Publikováno v:
Tumour Virus Research, Vol 12, Iss , Pp 200217- (2021)
ABSTRACT (198): Background: The multi-dose regimen is a known barrier to successful human papillomavirus (HPV) vaccination. Emerging evidence suggests that one vaccine dose could protect against HPV. While there are clear advantages to a single dose
Externí odkaz:
https://doaj.org/article/cd1621b57d6d40338b060f6ad6f62bd8
Autor:
Marygoreth J. Changalucha, Martha F. Mushi, Rodrick Kabangila, Vitus Silago, Beda Likonda, Stephen E. Mshana
Publikováno v:
Journal of Cancer Epidemiology, Vol 2020 (2020)
Background. A high mortality has been reported during the first ninety days of cancer therapy and is more pronounced in patients with febrile neutropenia. The Bugando Medical Center oncology department offers cancer diagnosis and treatment services t
Externí odkaz:
https://doaj.org/article/4f06577740a94182940a7f4a8bbf92e8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Tropical Medicine & International Health. 26:1345-1355
Cervical cancer is the leading cause of cancer-related morbidity and mortality in many sub-Saharan African (SSA) countries, including Tanzania. Most cervical cancer cases worldwide are attributable to infection of the cervix with Human Papillomavirus
Autor:
V Struckmann, V Stephani, A Hsiao, D Mbbando, J Changalucha, K Baisley, A Levin, R Hutubessy, D Watson-Jones, W Quentin
Publikováno v:
European Journal of Public Health. 32
Background Cervical cancer caused by human papillomavirus (HPV) is the most frequent cancer in women in many low-income countries.Tanzania implemented a national HPV vaccination program in 2018 using a two-dose quadrivalent HPV vaccine. This study ai
Autor:
G. Marwerwe, Hilary S. Whitworth, Richard J. Hayes, Charles J.N. Lacey, K.R. Mitchell, J. Changalucha, Kathy Baisley, Deborah Watson-Jones, T. Erio, S de Sanjosé
Publikováno v:
Tumour Virus Research
Tumour Virus Research, Vol 12, Iss, Pp 200217-(2021)
Tumour Virus Research, Vol 12, Iss, Pp 200217-(2021)
(198) Background The multi-dose regimen is a known barrier to successful human papillomavirus (HPV) vaccination. Emerging evidence suggests that one vaccine dose could protect against HPV. While there are clear advantages to a single dose schedule, b
Autor:
Martha F. Mushi, Rodrick Kabangila, Beda Likonda, Stephen E. Mshana, Marygoreth J. Changalucha, Vitus Silago
Publikováno v:
Journal of Cancer Epidemiology
Journal of Cancer Epidemiology, Vol 2020 (2020)
Journal of Cancer Epidemiology, Vol 2020 (2020)
Background. A high mortality has been reported during the first ninety days of cancer therapy and is more pronounced in patients with febrile neutropenia. The Bugando Medical Center oncology department offers cancer diagnosis and treatment services t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marygoreth J Changalucha, MARTHA F. Mushi, Rodrick Kabangila, Vitus Silago, Beda Likonda, Stephen E. Mshana
Background A high mortality has been reported during the first ninety days of cancer therapy and is more pronounced in patients with febrile neutropenia. Bugando Medical Center, oncology department offers cancer diagnosis and treatment services to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0dcbe02efe46e34d620809049f763a49
https://doi.org/10.21203/rs.2.13191/v1
https://doi.org/10.21203/rs.2.13191/v1